AU3609484A - Ethylenediamine peptide derivatives - Google Patents
Ethylenediamine peptide derivativesInfo
- Publication number
- AU3609484A AU3609484A AU36094/84A AU3609484A AU3609484A AU 3609484 A AU3609484 A AU 3609484A AU 36094/84 A AU36094/84 A AU 36094/84A AU 3609484 A AU3609484 A AU 3609484A AU 3609484 A AU3609484 A AU 3609484A
- Authority
- AU
- Australia
- Prior art keywords
- ethylenediamine
- peptide derivatives
- peptide
- derivatives
- ethylenediamine peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH6436/83 | 1983-12-01 | ||
| CH643683 | 1983-12-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3609484A true AU3609484A (en) | 1985-06-06 |
Family
ID=4309613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU36094/84A Abandoned AU3609484A (en) | 1983-12-01 | 1984-11-30 | Ethylenediamine peptide derivatives |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0144290A3 (en) |
| JP (1) | JPS60136595A (en) |
| AU (1) | AU3609484A (en) |
| DK (1) | DK571484A (en) |
| ES (1) | ES8701142A1 (en) |
| GR (1) | GR81124B (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0486478A3 (en) * | 1984-08-06 | 1992-08-12 | The Upjohn Company | Renin-inhibiting peptides |
| WO1991006561A1 (en) * | 1989-10-27 | 1991-05-16 | The Upjohn Company | Method for treating hiv and other retroviruses and compounds useful therefor |
| FR2711990B1 (en) * | 1993-11-05 | 1995-12-08 | Exsymol Sa | Pseudodipeptide product having an imidazole group, and therapeutic, cosmetological and agrifood applications. |
| EP0775112A1 (en) * | 1994-08-05 | 1997-05-28 | Warwick International Group Limited | Bleach activators |
| JP4484897B2 (en) * | 1995-12-08 | 2010-06-16 | 生化学工業株式会社 | Method for producing amino alcohol derivative |
| GB9727123D0 (en) * | 1997-12-22 | 1998-02-25 | Int Centre Genetic Eng & Bio | Synthesis of diamines |
| AU6075400A (en) * | 1999-07-06 | 2001-01-22 | Vertex Pharmaceuticals Incorporated | N-substituted glycine derivatives |
| WO2005113582A1 (en) * | 2004-05-22 | 2005-12-01 | Boehringer Ingelheim International Gmbh | Substituted ethane-1,2-diamines for the treatment of alzheimer's disease |
| WO2006053043A2 (en) | 2004-11-10 | 2006-05-18 | Genzyme Corporation | Methods of treating diabetes mellitus |
| BRPI0607304A2 (en) * | 2005-01-26 | 2009-08-25 | Allergan Inc | compounds having analgesic and / or immunostimulant activity |
| EP2032134B1 (en) | 2006-05-09 | 2015-06-24 | Genzyme Corporation | Methods of treating fatty liver disease comprising inhibiting glucosphingolipid synthesis |
| US8304447B2 (en) | 2007-05-31 | 2012-11-06 | Genzyme Corporation | 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| AU2008307516B2 (en) | 2007-10-05 | 2011-11-17 | Genzyme Corporation | Method of treating polycystic kidney diseases with ceramide derivatives |
| WO2010014554A1 (en) | 2008-07-28 | 2010-02-04 | Genzyme Corporation | Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease |
| KR101687039B1 (en) * | 2008-10-03 | 2016-12-15 | 젠자임 코포레이션 | 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| EP3678700B1 (en) * | 2017-09-05 | 2024-06-19 | Merck Sharp & Dohme LLC | Compounds for reducing the viscosity of biological formulations |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4198398A (en) * | 1977-07-12 | 1980-04-15 | Derek Hudson | Enkephalin analogues |
| US4145337A (en) * | 1977-10-11 | 1979-03-20 | Hoffmann-La Roche Inc. | Aminoethylglycine containing polypeptides |
| GB2058077B (en) * | 1979-06-08 | 1983-03-09 | Szelke M | Enkephalin analogues |
| NO812612L (en) * | 1980-08-06 | 1982-02-08 | Ferring Pharma Ltd | ENZYME inhibitor. |
| CA1245217A (en) * | 1981-12-10 | 1988-11-22 | Joshua S. Boger | Renin inhibitory peptides having phe su13 xx deletion |
| FI843837L (en) * | 1983-02-07 | 1984-09-28 | Ferring Ab | ENZYMINHIBITORER. |
| US4661473A (en) * | 1984-03-27 | 1987-04-28 | Merck & Co., Inc. | Renin inhibitors containing peptide isosteres |
-
1984
- 1984-11-26 EP EP84810575A patent/EP0144290A3/en not_active Withdrawn
- 1984-11-30 AU AU36094/84A patent/AU3609484A/en not_active Abandoned
- 1984-11-30 DK DK571484A patent/DK571484A/en not_active Application Discontinuation
- 1984-11-30 ES ES538172A patent/ES8701142A1/en not_active Expired
- 1984-11-30 GR GR81124A patent/GR81124B/en unknown
- 1984-12-01 JP JP59252849A patent/JPS60136595A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0144290A3 (en) | 1987-05-27 |
| DK571484D0 (en) | 1984-11-30 |
| EP0144290A2 (en) | 1985-06-12 |
| GR81124B (en) | 1985-03-26 |
| DK571484A (en) | 1985-06-02 |
| ES8701142A1 (en) | 1986-11-16 |
| JPS60136595A (en) | 1985-07-20 |
| ES538172A0 (en) | 1986-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU575048B2 (en) | Carboxyalkyl peptide derivatives | |
| AU2290088A (en) | Halogen-aniline derivatives | |
| AU567140B2 (en) | Sulphonamido-benzamide derivatives | |
| AU571494B2 (en) | 1- phenyl-2-azole-ethylamino-carbonyl derivatives | |
| AU2951884A (en) | Tetrahydropyridazinone derivatives | |
| AU3609484A (en) | Ethylenediamine peptide derivatives | |
| AU3320184A (en) | Pyridoinole derivatives | |
| AU2983384A (en) | Spirosuccinimide derivatives | |
| AU570047B2 (en) | 3-phenyl-4-cyanopyrrole derivatives | |
| AU562795B2 (en) | Pyrrolo-thiazole derivatives | |
| AU3608284A (en) | Acylamino-s-triazine derivatives | |
| AU565020B2 (en) | 1-benzazepine derivatives | |
| AU3276284A (en) | Acylindole derivatives | |
| AU563515B2 (en) | 3-indolecarboxamide derivatives | |
| AU3022984A (en) | Formamidoxime derivatives | |
| AU573268B2 (en) | 2-azacycloalkylthiopenem derivatives | |
| AU3668384A (en) | Tetrazole-5-carboxamide derivatives | |
| AU558705B2 (en) | Gonadoliberine derivatives | |
| AU2559584A (en) | 2-cyano-imidazopyridine derivatives | |
| AU3492584A (en) | Phenylethanamine derivatives | |
| AU568527B2 (en) | Carboxy-thiazolopyrimidine derivatives | |
| AU567189B2 (en) | Azolyl-tetrahydrofuran-2-ylidene-methane derivatives | |
| AU2769084A (en) | Bispiperidine derivatives | |
| AU3540584A (en) | Pyrimidoisoquinoline derivatives | |
| AU566160B2 (en) | Azolyl-tetrahydrofuran-2-ylidene-methane derivatives |